| Literature DB >> 23286587 |
Farhad Jadidi-Niaragh1, Mehdi Yousefi, Ali Memarian, Mohammad Hojjat-Farsangi, Jalal Khoshnoodi, Seyed Mohsen Razavi, Mahmood Jeddi-Tehrani, Fazel Shokri.
Abstract
Little is known regarding the immunobiology of regulatory T (Treg) cells in hematopoietic malignancies, particularly in chronic lymphocytic leukemia (CLL). In the present study, we showed that the frequencies of CD8(+) and CD4(+) Treg cells were significantly increased in progressive as compared with indolent CLL patients and normal subjects. Enriched CD4(+) Treg cells induced a similar level of inhibition in polyclonally activated B cells and effector T cells from CLL patients and normal subjects. Our results suggest that the increase in circulating Treg cells may result in downregulation of tumor-specific immune response, leading to tumor expansion and disease progression.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23286587 DOI: 10.3109/07357907.2012.756110
Source DB: PubMed Journal: Cancer Invest ISSN: 0735-7907 Impact factor: 2.176